Effects of ELA on glucose homeostasis appeared to be more reliant on GLP-1, rather than apelin, receptors.<h4>Conclusion</h4>These studies highlight the clear therapeutic applicability of rationally designed GLP-1/apelin hybrid molecules for the treatment of obesity and T2DM. Here, APLN is linked to obesity due to melanocortin 4 receptor deficiency.